Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.
Qaseem A, Wilt T, Kansagara D, Horwitch C, Barry M, Forciea M, Fitterman N, Balzer K, Boyd C, Humphrey L, Iorio A, Lin J, Maroto M, McLean R, Mustafa R, Tufte J. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Annals Of Internal Medicine 2018, 168: 569-576. PMID: 29507945, DOI: 10.7326/m17-0939.Peer-Reviewed Original ResearchConceptsType 2 diabetesAmerican CollegePharmacologic therapyGlycemic controlGeneral healthScottish Intercollegiate Guidelines NetworkGuidelines International Network libraryClinical Systems ImprovementHemoglobin A1c targetPatient's general healthAmerican Diabetes AssociationAGREE II instrumentLife expectancyNational Guideline ClearinghouseCost of careA1C targetsNonpregnant adultsMost patientsPharmacologic treatmentClinical EndocrinologistsTreatment burdenDiabetes AssociationPatient preferencesChronic conditionsAdvanced age